Ubuvuzi bukoreshwa na Salmon PDRN mubuvuzi bwiza: Kurenga "Intanga ya Salmon" 

Meta Ibisobanuro
Shakisha siyanse iri inyuma ya Salmon PDRN kugirango ikire nyuma ya laser, kugenzura umuriro, hamwe nigisubizo cyo kurwanya gusaza. Imfashanyigisho ifatika kubiranga uruhu hamwe nabashinzwe ubuvuzi bwiza.

Iriburiro: Impamvu PDRN isaba kureba kabiri

Muri Mutarama 2026, umutwe wongeye gushimisha ubwiza bw'isi: “Ukuri ku Isura ya Salmon” . Byari ibintu byumvikana, virusi, kandi-nkibihe byinshi bya virusi-byabuze ingingo rwose.

Inyuma yizina ryubushotoranyi hari imwe muri nyinshi ubukanishi butandukanye biomolecules kwinjira mubuvuzi bwiza. Polydeoxyribonucleotide (PDRN) ntabwo arikindi kintu kiyobora gusa cyangwa icyuma cya kolagen. Ikora Inzira ebyiri, zibangikanye-Ibikorwa byo kwakirwa byimyanya ndangagitsina no gukiza nucleotide salvage-ko ntakindi kintu cyiza cyiza cyigana.

Nyamara urujijo rukomeje. Abaganga bavura PDRN na polynucleotide (PN). Ibicuruzwa byamamaza "ADN yita ku ruhu" udasobanukiwe no kugabanya ibiro bya molekile. Abagenzuzi mu Bushinwa no muri Amerika bagenda ahantu hatandukanye, bigatera umutwe kubahiriza kubahiriza ibicuruzwa ku isi.

Iyi ngingo yandikiwe abashinzwe gutegura, abayobozi b'amavuriro, hamwe n'abashinzwe ingamba ninde ukeneye kwimura impuha. Turasuzuma:

• Uwiteka Uburyo bwa reseptor itandukanya PDRN na PN nibintu bikura

• Ibimenyetso byihariye kuri post-laser na microneedling porogaramu

• Ivugurura ry'izina-Kubera iki "Marques Polynucleotide Cutoff" ihindura uburyo wanditse ibicuruzwa

• Intambwe ngenderwaho mubushinwa nicyo bivuze kuri 2026–2027 kwinjira mumasoko

Nta sensationalism. Nta “gitangaza” kivuga. Gusa ikimenyetso, gitandukanijwe nurusaku.

1. Gusobanura Molecule: Impamvu PDRN na PN Bidahinduka

1.1 Kwivanga kwa 2025

Kumyaka mirongo itatu, ubuvanganzo bwiza bwakoreshejwe PDRN na PN bisimburana. Byombi bikomoka kuri ADN. Byombi biva muri salmon cyangwa trout. Byombi bikoreshwa mugutera inshinge.

Iki cyari ikibazo. Abaganga b’amavuriro bahisemo ibicuruzwa bishingiye ku cyubahiro aho kuba molekulari ikwiranye, biganisha ku musaruro udasanzwe hamwe n’ubuvanganzo bw’amavuriro.

Muri Mutarama 2025, itsinda mpuzamahanga ry'ubushakashatsi riyobowe na Marques n'abandi. yatanze igisubizo cyubaka: Marques Polynucleotide Cutoff.

• PDRN (Polydeoxyribonucleotide): Uburemere bwa molekile <1500 kDa. Iminyururu migufi. A2A reseptor agonist. Uburyo bw'ibanze: ibimenyetso bya farumasi + salvage ya nucleotide.

• PN (Polynucleotide): Uburemere bwa molekile ≥ 1500 kDa. Iminyururu ndende. Ifite hydrogel. Uburyo bw'ibanze: gukanika imashini + hydration .

Ibisobanuro bivura:
Niba ibicuruzwa byawe bishingiye ibimenyetso birwanya inflammatory, gukora fibroblast, cyangwa angiogenezi ya VEGF, ukoresha PDRN-utitaye kubyo label ivuga. Niba ibicuruzwa byawe bishingiye kuzuza viscoelastic hamwe no gukomeza hydration, ukoresha PN.

1.2 Itandukaniro ryuburyo rigira ingaruka kumikorere

Ibyingenzi byingenzi kubirango:
Gukoresha "PN" kugirango usobanure urunigi rugufi rwa PDRN ntabwo aribyo gusa - birayobya abaganga kubijyanye nuburyo buteganijwe nigihe bizamara.

2. Uburyo bwibikorwa: Inzira ebyiri zisobanura PDRN

Bitandukanye na biomolecules nziza cyane ikora Ingaruka imwe, PDRN ikora binyuze inzira ebyiri zigenga ariko zihuza inzira .

2.1 Inzira ya mbere: Gukora A2A Kwakira

PDRN ni agoniste yatoranijwe ya adenosine A2A yakira—A G-proteine ihujwe na reseptor yerekanwe kuri fibroblast, selile endothelia, na selile selile.

Guhuza imbarutso:

• CAMP (cyclic adenosine monophosphate) - ikimenyetso kidasanzwe cyerekana ko ibikorwa bya A2A byabayeho

• ↓ Guhindura NF-κB—Gabanya transcript ya cytokine itera umuriro (TNF-α, IL-1β, IL-6)

• EG VEGF (imiyoboro y'amaraso ikura)

• Synthesis Sintezez ya kolagen I / III- byahujwe no kugabanya MMP-1 no kugenzura TGF-β

Ibimenyetso biva mu mirima yegeranye:
A 2025 Ubumenyi ubushakashatsi kuri colitis ulcerative yemeje ko ubufatanye bwa DMPX (A2A antagonist) yavanyweho burundu PDRN yo kurwanya inflammatory na VEGF-igenzura. Ubu ni bwo buryo bumwe bwo kwakirwa bukoreshwa muri fibroblast ya dermal.

Ubuvuzi bwa Clinical:
Iyo PDRN yagejejwe kuruhu rwangiritse - haba hakoreshejwe inshinge, microneedling, cyangwa infashanyo ifashwa na laser - byerekana neza tissue kugirango ihindurwe iva muburyo bwo gusana. Iyi ntabwo ari imirire yuzuye. Ubu ni ubuvuzi bwa farumasi .

2.2 Inzira ya kabiri: Agakiza Inzira Nucleotide Itanga

Uturemangingo twakomeretse na hypoxic duhura n'ikibazo cy'ingufu. De novo nucleotide synthesis-Uburyo budasanzwe bwakagari bwo kubaka ADN ibanziriza-ni ogisijeni nyinshi kandi ihenze cyane.

PDRN itanga ubundi buryo.

Iyo PDRN ihuye nigabanuka ryimisemburo, irekura bioavailable nucleoside na nucleotide Injira i inzira y'agakiza. Ibi bisubiramo ibice byashizweho mbere muri synthesis ya ADN, bikanyura inzira ihenze cyane de novo.

Impamvu ibi bifite akamaro mubuvuzi bwiza:

• Uruhu rwa nyuma ya laser ni guhangayikishwa cyane na hypoxic

• Fibroblast ikenera nucleotide kugirango igwire kandi ikomatanye na kolagen

• PDRN itanga ibikoresho byihuse mugihe icyarimwe cyerekana binyuze kuri A2A kugeza kugenzura imashini zo gusana

Ntakindi kintu cyiza cyiza gikora byombi.

3. Ubuvuzi bukoreshwa: Ibimenyetso byuburyo bukurikirana

3.1 Nyuma ya Laser Yongeye Kugaruka: Ibyiza-Bishyigikiwe Byiza

Ikibazo:
Igice cya laser cyongeye kugaragara gikomeretsa ubushyuhe bwumuriro. Nubwo ari ingirakamaro mu kuvugurura, biratera igihe kirekire erythema, edema, hamwe nabarwayi igihe cyo hasi. Mu mateka, abaganga bemeye ko bidashoboka.

Igisubizo cya PDRN:
Ubushakashatsi bwerekana imbeba ya 2017 na Yu na Lee bwerekanye ko Ibikomere byavuwe na PDRN byerekanaga cyane selile nziza ya VEGF na microcessel ya CD31 ugereranije no kugenzura. Kongera epithelialisation byihuse. Umuriro wagabanutse vuba.

Isaro rya Clinical:
PDRN ntabwo "ibuza" gukomeretsa laser - ni guhagarika icyiciro cyo gutwika na yongerera icyiciro icyiciro. Abarwayi baracyatukura, ariko bo gusohoka umutuku byihuse .

2026 ubushishozi bwa protocole:
Amavuriro akomeye yo muri Amerika avugurura ubu akoresha PDRN nka an ongeraho Kuri isura nziza na laser - ntabwo ari "igitangaza" cyihariye, ariko nka a ibinyabuzima byongera amajwi y'ibidukikije bikiza.

3.2 Microneedling hamwe na PDRN: Gukoresha ibikoresho bifasha

Microneedling irema Imiyoboro ihanamye ibyo kurenga kuri bariyeri ya corneum. Ibi ntabwo ari ugutanga gusa - micro-injury ubwayo ikora platine kandi igashaka selile zo gusana .

Iyo PDRN ari gushiramo mugihe cya microneedling, uburyo bubiri buhuza:

1. Umubiri: PDRN igera kuri dermis idashingiye kumyumvire ikemangwa "transdermal"

2. Ibinyabuzima: Microneedling-iterwa no gutwikwa ni Byahinduwe na PDRN ya A2A agonism

Ibisubizo byagaragaye (ivuriro-byatangajwe):

• Kugabanya nyuma yuburyo bwa erythema igihe

• Gusubira byihuse kwisiga (akenshi amasaha 24 na 48–72)

• Kunoza imyambarire yiterambere hejuru ya 3-6 y'uruhererekane

Ubuvumo:
Ingingo ya PDRN ikoreshwa kuruhu rwiza hanze gufashwa gutanga bisigaye bikora neza. Abavuzi ba Dermatologue babajijwe muri Gashyantare 2026 bagaragaje gushidikanya ko inyungu zigaragara muri serumu ya PDRN ikomoka kuri PDRN ubwayo -Ibikoresho byunganira birashobora kuba ibikorwa byukuri .

3.3 Kurwanya Kurwanya: Kurenga nyuma yuburyo bukurikira

Indwara idakira yo mu rwego rwo hasi iranga uruhu rusaza, uruhu rworoshye, na fenotipike ikunda kwibasirwa na rosacea. Imiti gakondo irwanya inflammatory (corticosteroide, calcineurin inhibitor) ikora neza ariko idakwiriye kubungabungwa igihe kirekire.

PDRN itanga a itari steroidal, igengwa na physiologique uburyo bwo kurwanya inflammatory.

Ibimenyetso:

• Gukora A2A guhagarika NF-κB, kugabanya transcript ya TNF-α na IL-6

• IL-10 (anti-inflammatory cytokine) irateganijwe

• Kwinjira kwa VEGF ishyigikira ubunyangamugayo bwamaraso, kugabanya erythma idahwema

Intego ya Clinical:
Abarwayi badashobora kwihanganira retinoide kubera inzitizi za bariyeri barashobora kubyungukiramo PDRN nkumukozi wo kubungabunga ibikorwa, ikoreshwa ifatanije na exfoliation yoroheje na Photoprotection.

4. Ahantu nyaburanga: 2026 Imiterere ningamba zifatika

4.1 Ubushinwa: Ibikorwa by'ingenzi bya NMPA

Kuva muri Mata 2025, ibigo birindwi gusa yari yarangije ibikoresho byubuvuzi bya PDRN byanditse muri NMPA y'Ubushinwa. Lingmei Biotechnology (Hubei Lingmei) yabaye karindwi ku ya 16 Mata 2025.

Igihe:

• Kwiyandikisha muri dosiye nkuru: 2025 Q2

• Igeragezwa rya Clinical: Bigereranijwe 2025 Q3

• Icyiciro cya III giteganijwe kwemezwa ibikoresho byubuvuzi: 2026 Q4

Icyo ibi bivuze:

• Nta PDRN yujuje ibisabwa iraboneka mubushinwa

• Ibicuruzwa byagurishijwe bishingiye kwiyandikisha kwisiga cyangwa imipaka yambukiranya imipaka e-ubucuruzi

• Ibirango-byimuka byambere hamwe nibikoresho byemewe byo mucyiciro cya III bizafata umugabane wingenzi ku isoko mpera za 2026

Iterambere rifatanije:
SEOHO LAB yarangije kwiyandikisha uruhushya rwa NMPA PDRN Ukuboza 2025, gukuraho inzitizi zoherezwa mu mahanga kuri amavuta yo kwisiga Ibicuruzwa bya PDRN.

Uburyo bwo gufata ingamba:
Injiza PDRN hamwe na PDRN yibanze biratandukanya inzira zubuyobozi. Ibicuruzwa bigamije imiyoboro yubuvuzi bigomba gushyira imbere Icyiciro cya III kwandikisha ibikoresho. Ibicuruzwa byibanda kumiyoboro yabaguzi birashobora gukomeza Kumenyesha kwisiga kwa NMPA, ariko ugomba kwirinda gutanga ibirego bisa nibiyobyabwenge.

4.2 Amerika: Imiterere ya FDA

Nta bicuruzwa biterwa na PDRN byemewe na FDA kugirango bikoreshwe neza .

Gukoresha ivuriro bibaho hanze-label, mubisanzwe n'abaganga bo:

• Kuzana ibicuruzwa munsi yubusa

• Guteranya PDRN muburyo bwa farumasi

• Koresha microneedling-ifashwa no gutanga ibintu (ntabwo bigize inshinge)

Ingingo yibanze ya PDRN bigengwa no kwisiga kandi ntibisaba FDA mbere yo kubyemeza. Ariko FDA ntabwo yashyizeho monografiya ya PDRN, na ibipimo by'uburemere bwa molekile ntibihari- bisobanura ibicuruzwa bibiri byanditseho "serumu ya PDRN" birashobora kuba birimo ibice bitandukanye byabaturage.

5. Ibitekerezo byo gushiraho ibicuruzwa n'ababikora

5.1 Uburemere bwa molekulari: Ibihinduka byihishe

Marques Cutoff (1500 kDa) ni a amazina y'izina, ntabwo a Ibisobanuro. Clinical efficacy iterwa no gukwirakwiza ibice, ntabwo uburemere bwa molekile gusa.

Ibimenyetso kuva 2018:
Hwang n'abandi. yerekanye ko urwego rwiza rwibice bya PDRN ningirakamaro muburyo bwiza bwo gukiza ibikomere. Mugufi cyane: gutesha agaciro byihuse, nta kimenyetso gihamye. Birebire cyane: kugabanya A2A bioavailable, imyitwarire yubukanishi isa na PN.

Ubuyobozi bwo gutegura:

• Gusaba isesengura ryuzuye ryo gusesengura uhereye kubatanga ibikoresho bibisi

• Wange ibisobanuro byerekana gusa "impuzandengo yuburemere bwa molekile"

• Kubyerekana nyuma yuburyo bwo gusana, ibice by'urunigi ruciriritse (50-500 kDa) irashobora gutanga uburyo bwiza bwa A2A

5.2 Sisitemu yo gutanga: Absorption Imperative

PDRN ni hydrophilique na-molekuline-yuburemere ugereranije nibikorwa byo kwisiga gakondo. Gukwirakwiza pasiporo binyuze muri stratum corneum idahwitse ni nto.

Ingamba zo gutanga zemewe:

Ikirango:
Niba utangije "murugo PDRN serumu," ugomba Cyangwa:

1. Gushora imari bioavailable ibice byubaka (ultra-low MW ibice), cyangwa

2. Emera ibyo ibinyabiziga (humectants, anti-inflammatories) itwara inyungu zo kwisiga ako kanya, hamwe na PDRN itanga umusanzu ingaruka zo kuvugurura ibintu mu byumweru kugeza ku mezi.

6. Imipaka ivuka nibibazo bidakemutse

6.1 Ibikomoka ku bimera / PDRN

Gakondo PDRN ni salmon-ikomoka. Ibidukikije, imyitwarire itanga amasoko, hamwe no kurwanya allergie y amafi byihutishije inyungu bishingiye ku bimera na fermentation ikomoka kubindi .

Imiterere y'ubu:

• Vegan PDRN (ikomoka kuri algae, ibinyabuzima byogukora) iraboneka mubucuruzi

• Urwego ni yagenewe kwigana A2A agonism

• Amavuriro maremare yubuvuzi ntarahari

Icyerekezo cya Dermatologue:
Ati: “Ibikomoka ku bimera bikurura uruhu rumwe mu ruhu kandi bitanga inyungu zimwe na salmon gakondo ya PDRN, ariko ntabwo bafite amakuru y’igihe kirekire y’ubuvuzi abashyigikira kugeza ubu.” - Nicole Lee, MD

6.2 PDRN muburyo bwo kuvura

Ejo hazaza ha PDRN birashoboka guhuza, ntabwo ari monotherapy.

Ibintu byavutse:

• PDRN + Exosomes: Sisitemu ya P.E.A.R.L ya AnteAGE ihuza PDRN hamwe na molekile ya exosome yerekana ibimenyetso bya porogaramu nyuma ya microneedling

• PDRN + Acide ya Hyaluronic: Gucukumbura mubisabwa hamwe na dermal; gukorana kugaragara mugukwirakwiza fibroblast

• PDRN + Ibintu bikura: Gukorana ibitekerezo; amakuru make yatangajwe

Impamvu zishingiye ku mavuriro:
PDRN itanga nucleotide substrate na A2A ikimenyetso. Exosomes nibintu bikura bitanga inyongera ya cytokine. Ibi ni byuzuzanya, ntibirenze.

6.3 Inzibacyuho ya Nomenclature: Ingaruka zubucuruzi

Marques Cutoff ni munsi y'umwaka umwe. Kwemererwa mugutanga amabwiriza, farumasi, nibisobanuro byubucuruzi bizatwara igihe.

Ingaruka ku bicuruzwa:

• Gukomeza kuranga urwego ruciriritse PDRN nka "PN" irashobora gutumira kugenzura nkuko ibisobanuro bishimangira

• Gusaba “PDRN” ibice biri hejuru ya 1500 kDa bivuguruza ibipimo bigaragara

• INCI ntikiravugururwa; ubucuruzi bwihuse buzashimangira abemera hakiri kare ijambo risobanutse

Umwanzuro: PDRN mugace ka 2026–2027

Salmon ikomoka kuri PDRN ntabwo ari imyambarire. Yakomeje imyaka mirongo itatu yo kwitabwaho rimwe na rimwe kubera ko imikorere yacyo ari ibinyabuzima shingiro, ntabwo biterwa ningendo .

PDRN icyo aricyo:

• Inzira ebyiri-inzira yo kuvugurura hamwe na yerekanye A2A agonism na salvage inzira bioactivite

• A. nyuma yihuta ushyigikiwe nibimenyetso byinyamaswa nubusobanuro

• A. Ibikoresho bitandukanye hamwe na molekuline itandukanijwe neza na PN

Icyo PDRN itari:

• “Igitangaza” gihindagurika

• FDA yemerewe gutera inshinge muri Amerika

• Ibicuruzwa bisanzwe -gukwirakwiza ibice

Ku bakora umwuga w'ubuvuzi bwiza:

• Suzuma PDRN nka an umugereka, ntabwo ari umusimbura

• Shyira imbere yafashijwe gutanga (microneedling, laser) hejuru ya pasiporo yibanze

• Komeza kubimenyeshwa NMPA Icyiciro cya III cyemewe—Bazavugurura isoko rya Aziya muri 2026–2027

Kubirango byita kuruhu:

• Kugenzura amazina yawe. Urimo kugurisha PDRN cyangwa PN? Urashobora kubyemeza?

• Niba itangizwa mu Bushinwa, tandukanya ingamba zawe zo kwisiga no kwisiga

• Niba utangiza ibikomoka ku bimera PDRN, mu mucyo kubyerekeranye no kubura amakuru maremare yo kugereranya

Imitwe ya "salmon sperm" izakomeza. Buri gihe barabikora.

Inyuma yabo, biomolecule yemewe irimo gukusanya ibimenyetso bucece, kunonosora ibisobanuro byayo, no kwitegura icyiciro gikurikira cyo gukura kwa clinique.

PDRN ikwiye kurenza icyamamare cya virusi. Birakwiye gukurikizwa neza, kuranga ukuri, no kwinjiza muri protocole nshya yubahiriza ubushobozi bwayo nimbibi zayo.